Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vitro results show potency of novel bispecific HIV-1-neutralizing antibody

March 13, 2012

Dendritic cell-based vaccine is safe in patients with HIV

March 12, 2012

Recombinant protein therapy active against HIV in phase II trial

March 9, 2012

Gene-modified stem cell therapy shows promise to combat HIV infection

March 9, 2012

Canadian study assesses involvement of neuroinflammation in healthy aging humans

March 9, 2012

HCV NS3 resistance variants detected after 7-day MK-5172 course

March 8, 2012

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Novel SYK inhibitor shows potential as asthma therapeutic

March 7, 2012

New Taisho drug has promising pharmacological profile

March 7, 2012

Icatibant acetate may improve acquired angioedema

March 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...